Pharmaceutical manufacturer with 500+ drug formulations across 12 therapeutic areas
Yangtze River Pharmaceutical is a 18,000-person pharma manufacturer operating across 20+ subsidiaries with products meeting FDA, EU GMP, and Australian TGA standards. The hiring mix—sales and marketing represent 60% of active roles—reflects a company in expansion mode, while concurrent pain points around overseas market entry, GMP compliance, and clinical feedback collection signal scaling challenges typical of mid-size pharma moving international.
Notable leadership hires: Head Chef, Finance Department Head, Finance Director, Training Director, Technical Director
Founded in 1971, Yangtze River Pharmaceutical manufactures and distributes over 500 pharmaceutical preparations spanning 12 therapeutic areas. The company operates through 20+ subsidiary entities and maintains compliance with international regulatory bodies including US FDA and EU GMP. Products reach global markets from headquarters in Taizhou City, Jiangsu Province. Current operational focus includes brand promotion, product internationalization, GMP certification maintenance, and KOL network development. Active hiring spans sales, marketing, manufacturing, and research functions across China and the Netherlands.
The company employs over 18,000 people worldwide across 20+ subsidiary entities, with 431 active job openings as of the last reporting period.
Yangtze River Pharmaceutical actively recruits in China and the Netherlands, with the majority of roles concentrated in China across sales, marketing, and manufacturing functions.
The company meets US FDA, EU GMP, Australian TGA, and PIC/S standards. GMP compliance maintenance and certification are ongoing operational priorities.
Other companies in the same industry, closest in size